FLT3 (fms related receptor tyrosine kinase 3)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
2322 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Fms related receptor tyrosine kinase 3 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
FLT3 |
SynonymsGene synonyms aliases
|
CD135, FLK-2, FLK2, STK1 |
ChromosomeChromosome number
|
13 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
13q12.2 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
This gene encodes a class III receptor tyrosine kinase that regulates hematopoiesis. This receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia. [provided by RefSeq, Jan 2015] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs121909646 |
T>A,G |
Pathogenic |
Missense variant, non coding transcript variant, coding sequence variant |
rs121913232 |
G>C |
Pathogenic |
Missense variant, non coding transcript variant, coding sequence variant |
rs121913486 |
ATC>- |
Pathogenic-likely-pathogenic |
Inframe deletion, non coding transcript variant, coding sequence variant |
rs121913487 |
A>C,T |
Pathogenic |
Missense variant, non coding transcript variant, coding sequence variant |
rs121913488 |
C>A,G,T |
Pathogenic |
Missense variant, non coding transcript variant, coding sequence variant |
rs121913490 |
GAT>- |
Likely-pathogenic |
Inframe deletion, non coding transcript variant, coding sequence variant |
rs121913491 |
T>C |
Likely-pathogenic |
Missense variant, non coding transcript variant, coding sequence variant |
rs376588714 |
T>C |
Likely-pathogenic |
Coding sequence variant, non coding transcript variant, missense variant |
rs398122514 |
->TCCGGA |
Pathogenic |
Coding sequence variant, non coding transcript variant, inframe insertion |
rs587776834 |
TCA>- |
Pathogenic |
Non coding transcript variant, inframe deletion, coding sequence variant |
rs749281035 |
G>A,T |
Likely-pathogenic |
Non coding transcript variant, synonymous variant, missense variant, coding sequence variant |
rs772061268 |
T>G |
Likely-pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs864321619 |
->CATATTCTCTGAAATCAACGT |
Pathogenic |
Inframe insertion, coding sequence variant, non coding transcript variant |
rs991132188 |
T>C |
Likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1057519726 |
T>A,C,G |
Pathogenic, likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1057519762 |
A>G |
Likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1057519763 |
TC>AA |
Likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1057519764 |
A>C,T |
Likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1057519765 |
T>A,C |
Likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1057519766 |
G>C,T |
Likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1057519767 |
T>C |
Likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1057519768 |
T>C |
Likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1057519769 |
C>A |
Likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1057520021 |
A>C,G |
Likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1057520022 |
A>G |
Likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1057520023 |
A>C |
Likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1057520024 |
T>C |
Likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1057520025 |
A>G |
Likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1057520026 |
T>G |
Likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1057520043 |
A>C |
Likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1208575764 |
A>G |
Likely-pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1555256794 |
G>- |
Drug-response |
5 prime UTR variant, frameshift variant, coding sequence variant, non coding transcript variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
|
Transcription factors
|
Transcription factor |
Regulation |
Reference |
PML |
Activation |
17124055 |
STAT3 |
Activation |
16418395 |
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
P36888 |
Protein name |
Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) |
Protein function |
Tyrosine-protein kinase that acts as cell-surface receptor for the cytokine FLT3LG and regulates differentiation, proliferation and survival of hematopoietic progenitor cells and of dendritic cells. Promotes phosphorylation of SHC1 and AKT1, and activation of the downstream effector MTOR. Promotes activation of RAS signaling and phosphorylation of downstream kinases, including MAPK1/ERK2 and/or MAPK3/ERK1. Promotes phosphorylation of FES, FER, PTPN6/SHP, PTPN11/SHP-2, PLCG1, and STAT5A and/or STAT5B. Activation of wild-type FLT3 causes only marginal activation of STAT5A or STAT5B. Mutations that cause constitutive kinase activity promote cell proliferation and resistance to apoptosis via the activation of multiple signaling pathways. |
PDB |
1RJB
,
3QS7
,
3QS9
,
4RT7
,
4XUF
,
5X02
,
6IL3
,
6JQR
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF00047 |
ig |
255 → 345 |
Immunoglobulin domain |
Domain |
PF07714 |
PK_Tyr_Ser-Thr |
610 → 943 |
Protein tyrosine and serine/threonine kinase |
Domain |
|
Sequence |
|
Sequence length |
993 |
Interactions |
View interactions |
|
|